BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30606784)

  • 1. A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.
    Marques IDB; Araújo MJCLN; Graciolli FG; Dos Reis LM; Pereira RMR; Alvarenga JC; Custódio MR; Jorgetti V; Elias RM; Moysés RMA; David-Neto E
    J Am Soc Nephrol; 2019 Feb; 30(2):355-365. PubMed ID: 30606784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.
    Shane E; Cohen A; Stein EM; McMahon DJ; Zhang C; Young P; Pandit K; Staron RB; Verna EC; Brown R; Restaino S; Mancini D
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4481-90. PubMed ID: 23024190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
    Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Mitterbauer C; Steininger R; Grampp S; Klaushofer K; Delling G; Oberbauer R
    Kidney Int; 2003 Mar; 63(3):1130-6. PubMed ID: 12631097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study.
    Dabbaghmanesh A; Bakhshayeshkaram M; Roshanzamir S; Naseri A; Dabbaghmanesh MM; Heydari ST; Talehzadeh P; Dabbaghmanesh MH; Jahromi SE
    BMC Nephrol; 2023 Nov; 24(1):331. PubMed ID: 37940839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    Grey A; Horne A; Gamble G; Mihov B; Reid IR; Bolland M
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.
    Mainra R; Elder GJ
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):117-24. PubMed ID: 19965527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
    Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
    Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
    Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone microarchitecture following kidney transplantation-Beyond bone mineral density.
    Sharma AK; Toussaint ND; Elder GJ; Rajapakse CS; Holt SG; Baldock P; Robertson PL; Ebeling PR; Sorci OR; Masterson R
    Clin Transplant; 2018 Sep; 32(9):e13347. PubMed ID: 29984421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
    Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
    Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trabecular bone score in kidney transplant recipients.
    Naylor KL; Lix LM; Hans D; Garg AX; Rush DN; Hodsman AB; Leslie WD
    Osteoporos Int; 2016 Mar; 27(3):1115-1121. PubMed ID: 26608055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
    Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
    BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
    Goenka S; Sethi S; Pandey N; Joshi M; Jindal R
    Spinal Cord; 2018 Dec; 56(12):1207-1211. PubMed ID: 30258212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized Controlled Trial.
    Granild-Jensen JB; Møller-Madsen B; Rackauskaite G; Farholt S; Søndergaard C; Sørensen TH; Vestergaard ET; Langdahl BL
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2840-2851. PubMed ID: 37235798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty.
    Aro E; Moritz N; Mattila K; Aro HT
    J Biomech; 2018 Jun; 75():35-45. PubMed ID: 29747966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study.
    Fu GT; Lin LJ; Sheng PY; Li CC; Zhang JX; Shen J; Liu S; Xue YL; Lin SP; Wang K; Zheng QJ; Ding Y
    Orthop Surg; 2019 Aug; 11(4):653-663. PubMed ID: 31456320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
    Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
    Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.